Funding for this research was provided by:
Hector Stiftung II
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 6 October 2023
Accepted: 11 January 2024
First Online: 8 February 2024
Conflict of interest
: S. Loges: Advisory role for Lilly, Sanofi, BerGenBio, Novartis, Boehringer Ingelheim BMS, Roche, AstraZeneca, MSD, Merck, Sanofi-Aventis, Janssen, Takeda, Pfizer, Amgen, Bayer, Medac, Daiichi-Sankyo; honoraria and travel costs from Lilly, Sanofi, BerGenBio, Novartis, Boehringer Ingelheim, BMS, Roche, AstraZeneca, MSD, Merck, Sanofi-Aventis, Janssen, Takeda, Pfizer, Amgen, Bayer, Medac, Daiichi-Sankyo; research grants (to institution) from Roche, BerGenBio, Lilly, ADC Therapeutics, Daiichi-Sankyo. M. Janning: honoraria and/or advisory board from Roche, Amgen, AstraZeneca, Novartis, Takeda and travel support from AstraZeneca. Y. Sharapova declares that she has no competing interests.